Hormonal properties of 19-nortestosterone-homofarnesate (DA 1979), a new anabolic agent.
D045930:Anabolic Agents / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004231:Diuresis / Q000187:drug effects; D004353:Drug Evaluation, Preclinical; D005233:Fatty Alcohols / Q000494:pharmacology; D005260:Female; D006066:Gonads / Q000187:drug effects; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D051379:Mice; D009277:Nandrolone / Q000494:pharmacology*; D009318:Natriuresis / Q000187:drug effects; D009929:Organ Size; D011188:Potassium / Q000652:urine; D011817:Rabbits; D051381:Rats; D013737:Testis / Q000187:drug effects; D013950:Thymus Gland / Q000187:drug effects; D014599:Uterus / Q000187:drug effects
D045930:Anabolic Agents; D005233:Fatty Alcohols; D008112:Liver Glycogen; D009277:Nandrolone; D011188:Potassium